Summit Therapeutics SMMT Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's change in other assets?
- Summit Therapeutics (SMMT) reported change in other assets of $1.03M in Q1 2026.
- How has Summit Therapeutics's change in other assets changed year-over-year?
- Summit Therapeutics's change in other assets decreased by 27.7% year-over-year, from $1.42M to $1.03M.
- What is the long-term trend for Summit Therapeutics's change in other assets?
- Over 4 years (2021 to 2025), Summit Therapeutics's change in other assets has grown at a 161.5% compound annual growth rate (CAGR), from -$104K to -$4.87M.
- What does change in other assets mean?
- The net change in miscellaneous assets that are not classified as cash, inventory, or accounts receivable.
- How do you interpret change in other assets?
- A decrease indicates cash outflow for prepayments or other assets, while an increase indicates a source of cash from asset liquidation or reduction.
- How does change in other assets compare across companies?
- Commonly reported by all public companies; variations depend on the scale of prepaid expenses and deferred costs.